• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolit

tetano

Editor, Senior Moderator
J Med Virol


. 2022 May 16.
doi: 10.1002/jmv.27861. Online ahead of print.
Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India


Kayzad Nilgiriwala[SUP] 1 [/SUP], Pratibha Kadam[SUP] 1 [/SUP], Grishma Patel[SUP] 1 [/SUP], Ambreen Shaikh[SUP] 1 [/SUP], Tejal Mestry[SUP] 1 [/SUP], Smriti Vaswani[SUP] 1 [/SUP], Shalini Sakthivel[SUP] 1 [/SUP], Aruna Poojary[SUP] 2 [/SUP], Bhavesh Gandhi[SUP] 2 [/SUP], Seema Rohra[SUP] 2 [/SUP], Zarir Udwadia[SUP] 2 [/SUP], Vikas Oswal[SUP] 3 [/SUP], Daksha Shah[SUP] 4 [/SUP], Mangala Gomare[SUP] 4 [/SUP], Kalpana Sriraman[SUP] 1 [/SUP], Nerges Mistry[SUP] 1 [/SUP]



Affiliations

Abstract

The present study was initiated to understand the proportion of predominant variants of SARS-CoV-2 in post-vaccination infections during the Delta dominated second wave of COVID-19 in the Mumbai Metropolitan Region (MMR) in India and to understand any mutations selected in the post-vaccination infections or showing association with any patient demographics. Samples were collected (n=166) from severe/moderate/mild COVID-19 patients who were either vaccinated (COVISHIELD/COVAXIN - partial/fully vaccinated) or unvaccinated, from a city hospital and from home isolation patients in MMR. A total of 150 viral genomes were sequenced by Oxford Nanopore sequencing and the data of 136 viral genomes were analyzed for clade/lineage and for identifying mutations. The sequences belonged to three clades (21A, 21I and 21J) and their lineage was identified as either Delta (B.1.617.2) or Delta+ (B.1.617.2 + K417N) or sub-lineages of Delta variant (AY.120/AY.38/AY.99). A total of 620 mutations were identified of which 10 mutations showed an increase in trend with time (May-Oct 2021). Associations of 6 mutations (2 in spike, 3 in orf1a and 1 in nucleocapsid) were shown with milder forms of the disease and one mutation (in orf1a) with partial vaccination status. The results indicate a trend towards reduction in disease severity as the wave progressed. This article is protected by copyright. All rights reserved.

Keywords: Epidemiology; Genetics; Mutation; SARS coronavirus; Virus classification.
 
Back
Top Bottom